@misc{indiciaeaa0f09848e6c,
  title = {SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer},
  author = {Phoenix, J. T. and Budreika, A. and Schmeck, D. A. and Kostlan, R. J. and Ferrari, M. G. and Young, K. S. and Rogers, C. S. and Deegan, C. D. and Bergom, H. E. and Boytim, E. and Brown, R. M. and Bienko, M. W. and Walewicz, J. A. and Bhagi, S. K. and Ellis, L. and Antonarakis, E. S. and Drake, J. M. and Bawa, P. S. and Vellky, J. E. and Williams, A. and Reizine, N. M. and Rennhack, J. P. and Fanning, S. W. and Hwang, J. H. and Szmulewitz, R. Z. and Vander Griend, D. J. and Kregel, S.},
  year = {2025},
  doi = {10.1101/2025.07.18.664790},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.18.664790v1},
  note = {Source identifier: 10.1101/2025.07.18.664790}
}